These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23732241)

  • 1. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong.
    Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ
    Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SC; Ng SS; Sung JJ
    Am J Gastroenterol; 2014 Jul; 109(7):1072-9. PubMed ID: 24935273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regret on choice of colorectal cancer screening modality was associated with poorer screening compliance: a 4-year prospective cohort study.
    Wong MC; Ching JY; Chan VC; Bruggemann R; Lam TY; Luk AK; Wu JC; Chan FK; Sung JJ
    PLoS One; 2015; 10(4):e0125782. PubMed ID: 25875160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
    Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
    J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese.
    Wong MC; Tsoi KK; Ng SS; Lou VW; Choi SY; Ling KW; Chan FK; Griffiths SM; Sung JJ
    Aliment Pharmacol Ther; 2010 Jul; 32(1):74-82. PubMed ID: 20345501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening for colorectal cancer: compliance in Almopea Region.
    Chrissidis T; Saliangas K; Economou A; Nikoloudis N; Andreadis E; Prodromou K; Georgakis K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s193-5. PubMed ID: 15655620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should prior FIT results be incorporated as an additional variable to estimate risk of colorectal neoplasia? A prospective study of 5,813 screening colonoscopies.
    Wong MC; Ching JY; Chan VC; Shum JP; Lam TY; Luk AK; Sung JJ
    PLoS One; 2014; 9(12):e114332. PubMed ID: 25479102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
    Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
    Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
    Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
    Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district.
    Grazzini G; Ventura L; Zappa M; Ciatto S; Confortini M; Rapi S; Rubeca T; Visioli CB; Halloran SP
    Gut; 2010 Nov; 59(11):1511-5. PubMed ID: 20603498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.